Las redes eléctricas tienen potencial para aumentar la biodiversidad y conectar fauna fragmentada

by DiCYT - Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología

Las infraestructuras eléctricas pueden convertirse en corredores ecológicos para la pequeña fauna modificando la base de las torres de alta tensión

Read more

Microptic, new member of LABMAS

by MICROPTIC S.L.

Microptic, as a world leading Spanish comp​any in the field of semen analysis, just joined the association LABMAS (Laboratory Equipment Manufacturers Association of Spain),

Read more

Organismos Notificados: Team-NB – Guia evaluación de cambios significativos

by Tecno-med Ingenieros

La Asociación Europea de Organismos Notificados de Productos Sanitarios TEAM-NB publica esta guia para los cambios significativos.

Read more

CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor

by Ysios Capital

CorWave raises 35 million euros to fund the next stages of its development, with the ambition to become a world-class medtech company serving heart failure patients. The capital increase is subscribed...

Read more

Ramon Capella Armengol: a life fully dedicated to Telstar

by Telstar

In memory of Ramon Capella Armengol, Telstar’s founder and first president. A vastly accomplished businessman and entrepreneur who pioneered Telstar’s consolidation and expansion process until the...

Read more

Marta Rayo Lunar- New Scientific and Regulatory Affairs Director at Asphalion

by Asphalion

Asphalion’s Board of Directors is pleased to announce the appointment of Marta Rayo Lunar as new Scientific and Regulatory Affairs Director.

Read more

A laboratory at the IQAC-CSIC obtains the biosafety level 2 accreditation

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

The Institute of Advanced Chemistry of Catalonia (IQAC-CSIC) has obtained the biosafety level 2 accreditation for one of its laboratories, which allows the laboratory to work with biological agents cl...

Read more

ORYZON to present a corporate update and to hold multiple virtual corporate activities in January-2021

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announce...

Read more

Una placenta artificial para aumentar la supervivencia de los prematuros extremos

by Fundació Sant Joan de Déu

El artefacto permitirá mantener al neonato en un entorno parecido al útero materno, conectado a un cordón umbilical artificial, y disminuir las secuelas neurológicas.

Read more

Seeking out predictive biomarkers for a longer-term response to immunotherapy against NSCLC

by VHIO

While the rapidly emerging arsenal of immune-based therapies continues to show great promise in more effectively tackling an increasing number of tumor types including melanoma and lung cancer, these ...

Read more

Sermes CRO: Novedades sobre el nuevo portal europeo de ensayos clínicos de la EMA (CTIs)

by Sermes CRO

​La Agencia Europea de Medicamentos (EMA) tiene como objetivo tener listo su sistema de información de ensayos clínicos (CTIS) en diciembre de 2021, comprometiéndose con este objetivo en la actua...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Ona Therapeutics Raises $86.6 Million Se...

by Ysios Capital

Proceeds to support clinical development of lead first-in-class progra...

Photos Stream